Taysha Gene Therapies Inc (TSHA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2020 | 12-2019 | 12-2017 | 12-2006 | |
| Assets | ||||
| Current Assets | ||||
| Cash & Cash Equivalents | 251,253 | N/A | N/A | N/A |
| Other current assets | 0 | 15 | 0 | 0 |
| TOTAL | $257,879 | $15 | $N/A | $N/A |
| Non-Current Assets | ||||
| PPE Net | 287 | N/A | N/A | N/A |
| Other Non-Current Assets | 715 | 0 | 0 | 0 |
| TOTAL | $1,002 | $N/A | $N/A | $N/A |
| Total Assets | $258,881 | $15 | $N/A | $N/A |
| Liabilities | ||||
| Current Liabilities | ||||
| Accounts payable and accrued liabilities | 1,994 | 0 | 0 | 0 |
| Accrued Expenses | 5,135 | 150 | N/A | N/A |
| TOTAL | $7,129 | $150 | $N/A | $N/A |
| Non-Current Liabilities | ||||
| Other Non-Current Liabilities | 450 | 0 | 0 | 0 |
| TOTAL | $450 | $N/A | $N/A | $N/A |
| Total Liabilities | $7,579 | $150 | $N/A | $N/A |
| Shareholders' Equity | ||||
| Shares Outstanding, K | 37,761 | N/A | N/A | N/A |
| Retained earnings | -61,126 | -1,115 | N/A | N/A |
| TOTAL | $251,302 | $-135 | $N/A | $N/A |
| Total Liabilities And Equity | $258,881 | $15 | $0 | $0 |